GRCE

$1.864.49%0.08

Grace Therapeutics Inc (GRCE)

Grace Therapeutics Inc Stock (GRCE) Forecast

The Grace Therapeutics Inc (GRCE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.59, representing a +39.46% increase from the current price of $1.86. The highest analyst price target is $3.58, and the lowest is $1.61.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month GRCE Price Target

Average 2.02 (+8.72% Upside)

Is Grace Therapeutics Inc (GRCE) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	42.93	Neutral
STOCH(9,6)	42.66	Neutral
STOCHRSI(14)	53.30	Neutral
MACD(12,26)	-0.06	Sell
ADX(14)	21.36	Neutral
William %R	-57.50	Neutral
CCI(14)	-44.43	Neutral

Buy: 0 · Sell: 1 · Neutral: 6Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	1.87 Sell	1.86 Sell
MA20	1.90 Sell	1.91 Sell
MA50	2.04 Sell	2.02 Sell
MA100	2.15 Sell	2.20 Sell
MA200	2.77 Sell	2.48 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, GRCE could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on GRCE, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 42.93 indicates that GRCE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 42.66 indicates that GRCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 53.30 indicates that GRCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 21.36 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
CCI (Commodity Channel Index): A CCI(14) value of -44.43 indicates that GRCE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term GRCE price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Grace Therapeutics Inc financial reports and earnings history, Grace Therapeutics Inc (GRCE) stock could reach $3.22 by 2030, $6.73 by 2040 and $11.97 by 2050. See the projected annual prices until 2050 of the Grace Therapeutics Inc stock below:

Grace Therapeutics Inc (GRCE) is expected to reach an average price of $3.97 in 2035, with a high prediction of $3.90 and a low estimate of $0.1691. This indicates an +113.63% change from the last recorded price of $1.86.
Grace Therapeutics Inc (GRCE) stock is projected to chart a bullish course in 2040, with an average price target of $6.77, representing an +264.00% change from its current level. The forecast ranges from a conservative $2.87 to a sky-high $6.73.
Our analysts predict Grace Therapeutics Inc (GRCE) to change +296.12% by 2045, soaring from $4.53 to an average price of $7.37, potentially reaching $9.56. While $4.53 is the low estimate, the potential upside is significant.
Grace Therapeutics Inc (GRCE) stock is expected to climb by 2050, reaching an average of $7.94, a +326.93% change from its current level. However, a wide range of estimates exists, with high and low targets of $11.97 and $8.11, respectively, highlighting the market's uncertainty.

Grace Therapeutics Inc Stock (GRCE) Year by Year Forecast

Grace Therapeutics Inc Stock (GRCE) Price Forecast for 2026

The predicted value for Grace Therapeutics Inc (GRCE) in 2026 is set at an average of $2.65. Estimates vary from a peak of $5.18 to a trough of $1.47, indicating an +42.62% surge from the present price of $1.86.

Month	Average	Low	High	Change from today's price
December, 2026	$2.20	$1.61	$3.58	+18.12%

Grace Therapeutics Inc Stock (GRCE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Grace Therapeutics Inc (GRCE) is $1.82, with a high forecast of $3.33 and a low forecast of $0.4677. This indicates an -2.11% decrease from the last price of $1.86.

Month	Average	Low	High	Change from today's price
January, 2027	$2.64	$2.00	$2.83	+41.84%
February, 2027	$1.96	$1.61	$3.33	+5.35%
March, 2027	$1.23	$1.09	$2.38	-34.09%
April, 2027	$0.9871	$0.7612	$1.39	-46.93%
May, 2027	$1.34	$0.4677	$1.34	-27.77%
June, 2027	$1.72	$1.35	$1.88	-7.27%
July, 2027	$1.78	$1.52	$2.07	-4.52%
August, 2027	$2.16	$1.68	$2.54	+16.26%
September, 2027	$2.04	$1.62	$2.30	+9.87%
October, 2027	$2.04	$1.75	$2.23	+9.93%
November, 2027	$1.90	$1.78	$2.19	+1.95%
December, 2027	$2.05	$1.83	$2.29	+10.08%

Grace Therapeutics Inc Stock (GRCE) Price Forecast for 2028

In 2028, Grace Therapeutics Inc (GRCE) is projected to reach an average price of $2.11, with a high projection of $4.20 and a low estimate of $0.8254. This indicates an +13.24% rise from the last price of $1.86.

Month	Average	Low	High	Change from today's price
January, 2028	$2.14	$1.85	$2.20	+14.99%
February, 2028	$2.40	$2.13	$2.61	+29.04%
March, 2028	$2.78	$2.36	$2.90	+49.53%
April, 2028	$2.86	$2.42	$3.08	+53.89%
May, 2028	$3.68	$2.57	$3.95	+97.79%
June, 2028	$3.63	$1.52	$4.20	+95.17%
July, 2028	$1.22	$0.8254	$4.10	-34.59%
August, 2028	$1.28	$1.14	$1.78	-31.30%
September, 2028	$1.47	$1.17	$1.57	-21.03%
October, 2028	$1.26	$0.9701	$1.68	-32.51%
November, 2028	$1.28	$1.15	$1.39	-31.37%
December, 2028	$1.29	$1.21	$1.62	-30.77%

Grace Therapeutics Inc Stock (GRCE) Price Forecast for 2029

The 2029 price forecast for Grace Therapeutics Inc Stock (GRCE) is $0.6144 on average, with a high prediction of $2.19 and a low estimate of $0.0612. This represents an -66.97% decrease from the previous price of $1.86.

Month	Average	Low	High	Change from today's price
January, 2029	$1.12	$1.02	$1.33	-39.56%
February, 2029	$0.2706	$0.1732	$1.25	-85.45%
March, 2029	$0.573	$0.0612	$0.6924	-69.20%
April, 2029	$1.01	$0.4435	$2.19	-45.92%
May, 2029	$1.21	$0.5977	$1.97	-35.04%
June, 2029	$0.6406	$0.24	$1.22	-65.56%
July, 2029	$0.2764	$0.1562	$0.6512	-85.14%
August, 2029	$0.4641	$0.3658	$0.4247	-75.05%
September, 2029	$0.2083	$0.1277	$0.6283	-88.80%
October, 2029	$0.3813	$0.0989	$0.8413	-79.50%
November, 2029	$0.7136	$0.3818	$0.7486	-61.63%
December, 2029	$0.5066	$0.4466	$1.34	-72.77%

Grace Therapeutics Inc Stock (GRCE) Price Forecast for 2030

Grace Therapeutics Inc Stock (GRCE) is expected to reach an average price of $1.10 in 2030, with a high forecast of $3.22 and a low forecast of $0.1114. This signifies an -40.61% decrease from the last price of $1.86.

Month	Average	Low	High	Change from today's price
January, 2030	$0.7089	$0.4472	$1.07	-61.89%
February, 2030	$0.8113	$0.6195	$1.04	-56.38%
March, 2030	$0.8836	$0.6419	$1.07	-52.49%
April, 2030	$1.01	$0.7454	$1.17	-45.88%
May, 2030	$1.26	$0.9178	$1.39	-32.31%
June, 2030	$1.59	$1.21	$1.82	-14.44%
July, 2030	$1.56	$1.32	$1.86	-15.90%
August, 2030	$2.20	$1.57	$2.65	+18.10%
September, 2030	$1.64	$0.5496	$3.22	-11.85%
October, 2030	$0.4319	$0.1114	$3.13	-76.78%
November, 2030	$0.7043	$0.2037	$0.7343	-62.13%
December, 2030	$0.4573	$0.2655	$0.8549	-75.42%

Similar to GRCE